Effective August 1, 2024, this database was discontinued. All content will remain searchable and be preserved online for historical purposes only until 2029.
Bullous Pemphigoid
What's New
Last Posted: Jan 24, 2025
- Clinical characteristics of bullous pemphigoid patients of different ages and the possible mechanism.
Xinyi Chen, et al. The Journal of dermatology 2025 0 - Association of HLA class II alleles and haplotypes with bullous and mucus membrane pemphigoid risk: A systematic review, a meta-analysis and a meta-regression.
Tarak Dhaouadi, et al. International journal of immunopathology and pharmacology 2024 0 3946320241296903 - HLA-Cw6 Polymorphism in Autoimmune Blistering Diseases.
Christian Ciolfi, et al. Biomolecules 2024 0 (9) - Two-sample Mendelian randomization analysis of causal relationship between eczema and autoimmune diseases.
Chunli Chen, et al. Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences 2024 0 (6) 932-942 - HLA alleles associated to susceptibility to gliptin-associated bullous pemphigoid in Italian patients.
Marco Andreani, et al. HLA 2024 0 (2) e15616 - Association of Genetic Variants of HLA-DQA1 with Bullous Pemphigoid Induced by Dipeptidyl Peptidase-4 Inhibitors.
Takeshi Ozeki, et al. The Journal of investigative dermatology 2023 0 - Relationship between pemphigus and American tegumentary leishmaniasis: insights from serological and genetic profiles.
Walsh Priscilla, et al. Transactions of the Royal Society of Tropical Medicine and Hygiene 2017 0 (8) 345-353 - Risk of venous thromboembolism in patients with bullous pemphigoid: A systematic review and meta-analysis.
Ungprasert Patompong, et al. Indian journal of dermatology, venereology and leprology 2017 0 (1) 22-26 - Haplotypes of ABCB1 1236C?>T (rs1128503), 2677G?>T/A (rs2032582), and 3435C?>T (rs1045642) in patients with bullous pemphigoid.
Rychlik-Sych Mariola, et al. Archives of dermatological research 2018 0 (6) 515-522 - Polymorphisms in the Mitochondrial Genome Are Associated With Bullous Pemphigoid in Germans.
Russlies Juliane, et al. Frontiers in immunology 2019 0 2200 - Genetic susceptibility of dipeptidyl Peptidase-4 inhibitor associated bullous pemphigoid in Chinese patients with type 2 diabetes.
Shi Mai, et al. Journal of the European Academy of Dermatology and Venereology : JEADV 2022 0 (3) e375-e377 - A multi-hit hypothesis of bullous pemphigoid and associated neurological disease: Is HLA-DQB1*03:01, a potential link between immune privileged antigen exposure and epitope spreading?
Amber K T, et al. HLA 2017 0 (3) 127-134 - Genotype-Guided Prescription of Azathioprine Reduces the Incidence of Adverse Drug Reactions in TPMT Intermediate Metabolizers to a Similar Incidence as Normal Metabolizers.
Casajús Ana, et al. Advances in therapy 2022 0 (4) 1743-1753 - Imputation of the major histocompatibility complex region identifies major independent variants associated with bullous pemphigoid and dermatomyositis in Han Chinese.
Fan Wencheng, et al. The Journal of dermatology 2022 6 - IL-13 Genetic Susceptibility to Bullous Pemphigoid: A Potential Target for Treatment and a Prognostic Marker.
Wang Yiman, et al. Frontiers in immunology 2022 0 824110 - Identification of two novel bullous pemphigoid- associated alleles, HLA-DQA1*05:05 and -DRB1*07:01, in Germans.
Schwarm Christian, et al. Orphanet journal of rare diseases 2021 5 (1) 228 - COL17A1 gene polymorphisms are frequent in bullous pemphigoid.
Tabatabaei-Panah P-S, et al. Journal of the European Academy of Dermatology and Venereology : JEADV 2021 4 - Dipeptidyl peptidase-4 inhibitor-related bullous pemphigoid: A comparative study of 100 patients with bullous pemphigoid and diabetes mellitus.
Chanprapaph Kumutnart, et al. The Journal of dermatology 2021 2 - TH17/IL23 cytokine gene polymorphisms in bullous pemphigoid.
Tabatabaei-Panah Pardis-Sadat, et al. Molecular genetics & genomic medicine 2020 12 e1519 - Association between TH2 Cytokine Gene Polymorphisms and Risk of Bullous Pemphigoid.
Tabatabaei-Panah Pardis-Sadat, et al. Immunological investigations 2020 10 1-13 - Proinflammatory Cytokine Gene Polymorphisms in Bullous Pemphigoid.
Tabatabaei-Panah Pardis-Sadat, et al. Frontiers in immunology 2019 0 636 - Biological predictors shared by dementia and bullous pemphigoid patients point out a cross-antigenicity between BP180/BP230 brain and skin isoforms.
Julio Tamiris A, et al. Immunologic research 2018 9 - The p.Arg435His Variation of IgG3 With High Affinity to FcRn Is Associated With Susceptibility for Pemphigus Vulgaris-Analysis of Four Different Ethnic Cohorts.
Recke Andreas, et al. Frontiers in immunology 2018 0 1788 - TNF-? -308G/A gene polymorphism in bullous pemphigoid and alopecia areata.
Moravvej Hamideh, et al. Human antibodies 2018 5 - HLA-C*17, DQB1*03:01, DQA1*01:03 and DQA1*05:05 Alleles Associated to Bullous Pemphigoid in Brazilian Population.
Chagury Azis Arruda, et al. Annals of dermatology 2018 2 (1) 8-12 - Association of HLA class I and class II alleles with bullous pemphigoid in Chinese Hans.
Fang Hui, et al. Journal of dermatological science 2017 12 - ABCB1 gene is associated with the risk of bullous pemphigoid in a polish population.
Rychlik-Sych Mariola, et al. Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG 2017 2 - The impact of the CYP2D6 gene polymorphism on the risk of pemphigoid.
Rychlik-Sych Mariola, et al. International journal of dermatology 2015 7 - Allelic and copy-number variations of Fc?Rs affect granulocyte function and susceptibility for autoimmune blistering diseases.
Recke Andreas, et al. Journal of autoimmunity 2015 7 36-44 - Polymorphisms in the mitochondrially encoded ATP synthase 8 gene are associated with susceptibility to bullous pemphigoid in the German population.
Hirose Misa, et al. Experimental dermatology 2015 9 (9) 715-7 - Association between HLA-DQB1*03:01 and Bullous pemphigoid in Iranian patients.
Esmaili N, et al. Iranian journal of immunology : IJI 2013 3 (1) 1 - Bullous pemphigoid
From NCATS Genetic and Rare Diseases Information Center - The role of Fc gamma receptors polymorphisms in bullous pemphigoid.
Guilabert Antonio, et al. Journal of the American Academy of Dermatology 2010 7 (1) 161-3 - Relevance of the low-affinity type of the Fcgamma-receptor IIIa-polymorphism in bullous pemphigoid.
Weisenseel P, et al. Archives of dermatological research 2007 6 (3) 163-4 - Cytokine gene polymorphisms in bullous pemphigoid in a Chinese population.
Chang Y T, et al. The British journal of dermatology 2006 1 (1) 79-84 - Genetic variation in COL17A1 and the development of bullous pemphigoid.
Winsey Samantha, et al. Experimental dermatology 2004 3 (3) 140-7 - HLA-DR and DQ polymorphisms in bullous pemphigoid from northern China.
Gao X-H, et al. Clinical and experimental dermatology 2002 6 (4) 319-21
About Rare Diseases PHGKB
Rare Disease PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other information that address the public health impact and translation of genomic and other precision health discoveries into improved health outcomes related to rare diseases...more
Content Summary
Selected Rare Diseases
Browse full list of rare diseases
A-Z
- Alpha-1 Antitrypsin Deficiency
- Amyotrophic Lateral Sclerosis
- Brugada Syndrome
- Cerebral Palsy
- Cystic Fibrosis
- Duchenne Muscular Dystrophy
- Eclampsia
- Erythema Multiforme
- Familial Mediterranean Fever
- Fragile X Syndrome
- Gaucher Disease
- Glomerulonephritis
- Graves Disease
- Hemophilia
- Huntington Disease
- Microcephaly
- Myasthenia Gravis
- Phenylketonuria
- Retinitis Pigmentosa
- Severe Combined Immunodeficiency
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by Public Health Genomics Branch to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Feb 1, 2024
- Content source: